Lilly's Weight Loss Sets High Bar for Obesity Drug Race
Source:
bloombergMarkets
June 9, 2026 · 10:59
Sam Fazeli, Director of Research for Global Industries and Senior Pharmaceuticals Analyst for Bloomberg Intelligence, joined Bloomberg's Scarlett Fu and Paul Sweeney to discuss the gains and losses in the GLP1 market. (Source: Bloomberg)
The original article opens on the publisher's website.
More from Economy
View topic →China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says
cnbc
Sep 1, 2026 · 16:52
US diesel prices soar as Trump hauls in refiners
financialTimes
Sep 1, 2026 · 14:18
Anthropic's Claude Fable 5.1 and Mythos 5.1 arrive with a 75% cost reduction for Fable cache reads
ventureBeat
Sep 1, 2026 · 11:41
Prediction market traders think job creation rebounded in August
cnbc
Sep 1, 2026 · 11:16
Your files stay put: Perplexity’s hybrid AI keeps confidential data off the cloud
ventureBeat
Sep 1, 2026 · 08:00